Teleflex (TFX) Akcija Cena
Teleflex Cena
Teleflex ieņēmumi saruka par 1,5 % gadā pēdējos 19 gados līdz 1,99 B USD. Peļņa uz akciju samazinājās par 4,6 % gadā pēdējos 18 gados. Teleflex neto marža tagad ir -45,4 %, samazinājusies no 17,3 % pirms dažiem gadiem. Teleflex pašlaik piedāvā dividenžu ienesīgumu ap 1,04 %. Dividendes auga par 1,1 % gadā pēdējos 19 gados. Analītiķu mērķa cenas mediāna ir 156,50 USD, t. i. virs pašreizējo cenu par 19,8 %. No 19 analītiķiem 8 iesaka pirkt — kopējais konsenss ir Turēt.
Teleflex akcijas cena
Iegūstiet šos datus caur Eulerpool API
100 000 pieprasījumu/mēn. bez maksas · bez kartes
Teleflex biznesa modelis un akciju analīze
Bieži uzdotie jautājumi par Teleflex akciju
Teleflex Inc is a leading global provider of medical technologies designed to enhance the health and well-being of patients. With a diverse product portfolio, the company specializes in the development, manufacturing, and distribution of innovative medical devices for a wide range of applications. Teleflex focuses on delivering high-quality solutions in critical care, surgical care, urology, and respiratory care, among others. By leveraging its expertise and strong market presence, Teleflex continuously aims to improve patient outcomes, increase healthcare efficiency, and advance medical innovation.
Teleflex Inc is primarily active in a variety of industries. As a global provider of medical technology products, the company focuses on healthcare, providing innovative solutions in the areas of surgical and diagnostic devices, anesthesia, and critical care. Teleflex Inc also has a presence in the aerospace industry, supplying specialized control systems and components for aircraft and helicopters. With its diverse portfolio, Teleflex Inc continues to make significant contributions in these sectors, driving advancements and improving patient outcomes in healthcare, while delivering reliable and efficient solutions in the aerospace industry.
The main competitors of Teleflex Inc in the market include Johnson & Johnson, Becton, Dickinson and Company, Medtronic plc, and Smiths Medical.
Teleflex Inc is a renowned company specializing in medical technology. Established in 1943, Teleflex has a rich history rooted in innovation and industry leadership. With headquarters in Wayne, Pennsylvania, the company has expanded globally, offering a diverse portfolio of medical devices that enhance patient care and improve clinical outcomes. Teleflex's dedication to research and development has led to breakthrough solutions in respiratory care, surgical instruments, urology, vascular access, and more. By combining cutting-edge technology with a commitment to quality, Teleflex continues to shape the healthcare industry, providing healthcare professionals with the tools they need to deliver superior patient care.
Teleflex Inc has achieved several significant milestones throughout its history. The company expanded its product portfolio by acquiring Arrow International in 2007, a leading manufacturer of critical care products. In 2011, Teleflex successfully launched the MANTA Vascular Closure Device, revolutionizing the way vascular access sites are closed after procedures. Additionally, the company received FDA clearance for the Teleflex UroLift System in 2013, providing a minimally invasive solution for enlarged prostate patients. In recent years, Teleflex also made significant advancements in its vascular access product line, including the introduction of the ARROW PICC with Chlorag+ard Technology. These achievements highlight Teleflex's continuous commitment to innovation and improving patient outcomes.
Teleflex Inc is primarily present in various countries and regions worldwide. The company has a strong global presence, with operations in North America, Europe, Asia Pacific, and Latin America. Teleflex serves customers and healthcare markets in over 150 countries, providing innovative solutions in medical technology and consumer healthcare. With its diverse portfolio of products and services, Teleflex Inc has established itself as a trusted provider in the medical device industry.
Teleflex Inc represents a set of core values and a corporate philosophy that guide its operations. With a focus on innovation and excellence, the company strives to deliver high-quality medical technology solutions to enhance patient outcomes. Teleflex is committed to providing world-class customer service, ensuring the best user experience for healthcare professionals and patients. With a dedication to integrity, teamwork, and continuous improvement, Teleflex values collaboration, transparency, and ethical conduct in all aspects of its business. By prioritizing customer needs and embracing a culture of innovation, Teleflex aims to make a positive impact in the healthcare industry.
Analītiķi pašlaik nosaka vidējo Teleflex akcijas mērķa cenu 153,88 USD (mediāna: 156,50 USD), kas ir +17,8 % pret pēdējo cenu. Konsenss balstās uz 19 analītiķu vērtējumiem.
19 analītiķi pašlaik vērtē Teleflex akciju: 8 iesaka pirkt, 11 turēt un 0 pārdot. 2026. gadam analītiķi sagaida, ka Teleflex gūs 2,27 B USD ieņēmumus un 7,67 USD peļņu uz akciju.
Pēc pašreizējā kursa Teleflex akcija maksā 116,51 EUR (130,67 USD).
Teleflex akcija (TFX) tiek kotēta 6 biržās, tostarp: NYSE (TFX), SIX (Zürich) (TBH.SW), XETRA (TBH.DE), Frankfurt (TBH.F), München (TBH.MU), Düsseldorf (TBH.DU).
Teleflex Inc. is an American company specializing in the manufacturing and selling of medical devices and instruments. It was founded in 1943 and has become a leading provider of medical products. The company divides its business into three main segments: Medical Devices, Anesthesia, and Interventional Medicine. Each segment offers a wide range of products tailored to the specific needs of the healthcare industry. The Medical Devices segment focuses on catheters, leads, drains, and other surgical instruments, while also offering specialized products for cardiology, oncology, and neurology. The Anesthesia segment specializes in products used in anesthesia applications, such as ventilation support devices and block needles. The Interventional Medicine segment focuses on treating and preventing vascular diseases with products like vascular access devices and balloon catheters used in minimally invasive procedures. This segment is the fastest-growing for Teleflex due to increasing demand for minimally invasive treatment methods. Teleflex has built a portfolio of over 30,000 products through acquisitions and internal innovations. Effective management, partnerships with doctors and hospitals, and participation in industry events ensure the company's growth and expansion. In summary, Teleflex Inc. is a company with a wide range of medical products used in various sectors of the healthcare industry. With a global presence and diverse product portfolio, the company can respond to changing customer desires and needs. Through continuous innovation, research, and development, Teleflex aims to revolutionize the healthcare industry and achieve higher levels of effectiveness and efficiency.
gaidāmā apgrozījums Teleflex ir 2,27 B USD. Šis skaitlis ir balstīts uz pašreizējiem finanšu datiem un atspoguļo uzņēmuma biznesa sniegumu.
gaidāmā peļņa Teleflex ir 339,29 M USD. Neto peļņa atspoguļo uzņēmuma rentabilitāti pēc visu izdevumu atskaitīšanas.
Teleflex cenas un peļņas rādītājs (P/E) pašlaik ir 17,04. P/E rādītājs salīdzina pašreizējo akcijas cenu ar peļņu uz akciju un palīdz ieguldītājiem novērtēt Teleflex akcijas vērtību.
Teleflex cenas un apgrozījuma rādītājs (P/S) pašlaik ir 2,55. P/S rādītājs salīdzina tirgus kapitalizāciju ar gada apgrozījumu un kalpo kā Teleflex akcijas vērtības mērs.
Teleflex Eulerpool kvalitātes rādītājs ir 0/10.
Teleflex ISIN ir US8793691069. ISIN (International Securities Identification Number) ir pasaulē unikāls vērtspapīru identifikators.
Teleflex WKN ir 855853. WKN (Wertpapierkennnummer) ir sešciparu vācu vērtspapīru identifikācijas numurs.
Teleflex tikeris ir TFX. Tikeris tiek izmantots Teleflex akciju tirdzniecībai biržā.
Teleflex akcija
Teleflex Salīdzināmo uzņēmumu grupa
Teleflex Biržas kods
Teleflex FIGI
Visi Teleflex fundamentālie rādītāji un padziļinātā analīze
Mūsu akciju analīze par Teleflex ietver svarīgus finanšu rādītājus, piemēram, apgrozījumu, peļņu, P/E rādītāju, P/S rādītāju, EBIT, kā arī informāciju par dividendēm. Turklāt mēs aplūkojam aspektus kā akcijas, tirgus kapitalizāciju, parādus, pašu kapitālu un saistības no Teleflex. Ja meklējat sīkāku informāciju par šīm tēmām, piedāvājam detalizētas analīzes mūsu apakšlapās: